Diabetes Drugs Market to Reach US$ 78,261.7 Mn by 2026, Deriving Growth from Increasing Drug Approvals, says Fortune Business Insights
26 juin 2019 07h56 HE
|
Fortune Business Insights
Pune, June 26, 2019 (GLOBE NEWSWIRE) -- The global Diabetes Drugs Market derives growth from advancements in drug delivery systems. According to a report published by Fortune Business Insights,...
The huge potential of GLP-1 receptor agonists in the diabetes market opens opportunities for technology providers and pharma companies
07 mai 2012 14h00 HE
|
La Merie SL
Stuttgart, Germany, May 7, 2012 (GLOBE NEWSWIRE) -- La Merie Publishing released a new analysis of
glucagon-like peptide-1 receptor (GLP-1R) agonists regarding
business, commercial, clinical and...